Abstract
The human body follows 24 hours cycles called the circadian rhythm that affect many physiological and physiopathological processes. Chronotherapeutic diseases include asthma, cardiovascular diseases, cancer, rheumatoid arthritis and other algesia processes. Drugs behaviours in the human body are also strongly affected by circadian changes, especially in what concerns absorption and elimination. Anti-inflammatory drugs are excellent candidates to chronotherapeutical delivery. Chronotherapeutic products are able to synchronize drug delivery with circadian rhythms in order to enhance efficacy and reduce side effects. These products mainly offer pulsatile release that follow a sigmoid release profile with a combination of periods of lag time and periods of fast drug release. Many technologies, either single units or multiparticulate systems, have been suggested and some have been successfully marketed improving patients adherence and quality of life. This review aims to describe the circadian rhythms and their influences in therapeutics as well as the technologies that have been proposed to develop chronopharmaceutical dosage forms.
Keywords: Circadian rhythm, chronotherapy, chronopharmaceutics, pulsatile drug delivery, Chronopharmacodynamics, Chronotherapeutics, Chronotoxicology, Duodenal Ulcer, Osmotic Controlled Devices, Reservoir Devices
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Chronopharmaceutical Delivery of Anti-Inflammatory Drugs
Volume: 10 Issue: 3
Author(s): Baratta P. and Lopes C.M.
Affiliation:
Keywords: Circadian rhythm, chronotherapy, chronopharmaceutics, pulsatile drug delivery, Chronopharmacodynamics, Chronotherapeutics, Chronotoxicology, Duodenal Ulcer, Osmotic Controlled Devices, Reservoir Devices
Abstract: The human body follows 24 hours cycles called the circadian rhythm that affect many physiological and physiopathological processes. Chronotherapeutic diseases include asthma, cardiovascular diseases, cancer, rheumatoid arthritis and other algesia processes. Drugs behaviours in the human body are also strongly affected by circadian changes, especially in what concerns absorption and elimination. Anti-inflammatory drugs are excellent candidates to chronotherapeutical delivery. Chronotherapeutic products are able to synchronize drug delivery with circadian rhythms in order to enhance efficacy and reduce side effects. These products mainly offer pulsatile release that follow a sigmoid release profile with a combination of periods of lag time and periods of fast drug release. Many technologies, either single units or multiparticulate systems, have been suggested and some have been successfully marketed improving patients adherence and quality of life. This review aims to describe the circadian rhythms and their influences in therapeutics as well as the technologies that have been proposed to develop chronopharmaceutical dosage forms.
Export Options
About this article
Cite this article as:
P. Baratta and C.M. Lopes, Chronopharmaceutical Delivery of Anti-Inflammatory Drugs, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2011; 10 (3) . https://dx.doi.org/10.2174/1871523011109030180
DOI https://dx.doi.org/10.2174/1871523011109030180 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A New Protocol of Type 2 Diabetes Induction and Hydrocortisone Effects on Beta-Cells Signaling in Mice
Current Chemical Biology Coumarin and Isocoumarin as Serine Protease Inhibitors
Current Pharmaceutical Design Current Status Of Short Synthetic Peptides As Vaccines
Medicinal Chemistry Inflammatory Mediators and the Failing Heart: A Translational Approach
Current Molecular Medicine Recent Advances in Small Molecule Inhibitors of VEGFR and EGFR Signaling Pathways
Current Topics in Medicinal Chemistry The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil
Current Respiratory Medicine Reviews Nanomaterial Based Affinity Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry for Biomolecules and Pathogenic Bacteria
Recent Patents on Nanotechnology NO-NSAIDs: From Inflammatory Mediators to Clinical Readouts
Inflammation & Allergy - Drug Targets (Discontinued) Peripheral Benzodiazepine Receptor Ligands and their Anti-Inflammatory Effects
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents New Insights into HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs
Current Topics in Medicinal Chemistry Liquid Chromatographic Analysis of Methotrexate and Minocycline-relevance to the Determination in Plasma/Nanoparticulate Formulations
Current Chromatography Pharmacological Targeting of IDO-Mediated Tolerance for Treating Autoimmune Disease
Current Drug Metabolism May Oxygen-Ozone Therapy Improves Cardiovascular Disorders?
Cardiovascular & Hematological Disorders-Drug Targets Henoch Schonlein Purpura in Childhood
Current Pediatric Reviews In Vivo Gamma Scintigraphic Evaluation and Determination of a Gastro-Resistant Etodolac Tablet in Humans
Combinatorial Chemistry & High Throughput Screening Pd/C-mediated Synthesis of 3-methyleneisoindolin-1-ones: Biological and Theoretical Study of their PDE4 Inhibition
Letters in Drug Design & Discovery Imaging Patterns of Cardiovascular Involvement in Mixed Connective Tissue Disease Evaluated by Cardiovascular Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Bee Venom: Its Potential Use in Alternative Medicine
Anti-Infective Agents Hydrogen Commonly Applicable from Medicine to Agriculture: From Molecular Mechanisms to the Field
Current Pharmaceutical Design